Compare Charles River Laboratories Intl. Inc (CRL) vs Kinder Morgan Inc (KMI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles River Laboratories Intl. Inc vs Kinder Morgan Inc — how do they compare? Charles River Laboratories Intl. Inc trades at $288.87 (market cap $13.46B), while Kinder Morgan Inc trades at $31.75 (market cap $70.10B). The key difference: Kinder Morgan Inc is far larger — about 5.2× Charles River Laboratories Intl. Inc's market cap, and Kinder Morgan Inc pays a 3.75% dividend while Charles River Laboratories Intl. Inc pays none. Which is the better fit depends on your goals.
| CRL | KMI | |
|---|---|---|
Market Cap | $13.46B | $70.10B |
Sector | Health | Energy |
52-Week High | $282.00 | $34.31 |
52-Week Low | $145.57 | $25.84 |
Enterprise Value | $16.30B | $102.15B |
Dividend Yield | — | 3.75% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Charles River Laboratories (CRL) trades at $284.37, up 2.66% today and near its 52-week high, reflecting strong bullish momentum. The stock has consistently beaten earnings estimates in recent quarters, including a Q2 2026 EPS of $3.02 versus $2.77 expected, and the company raised its full-year guidance. Despite negative net income margins, operating cash flow remains robust at $738 million in 2025. Analyst sentiment is overwhelmingly positive with 26 buy ratings and a consensus price target of $277.29.
The outlook is supported by improving biotech demand and cost controls, but high valuation multiples and recent insider selling pose risks. Earnings growth and margin expansion are key catalysts, though profitability challenges and macroeconomic sensitivity could pressure the stock. Investors should weigh strong technicals and analyst support against fundamental weaknesses and execution risks.
KMI trades at $31.70, up 0.99% on the day, with a bearish technical signal from moving averages. The company reported strong Q2 2026 earnings, beating estimates, and raised full-year guidance. Recent news highlights a $5 billion joint venture for the Western Gateway Pipeline, signaling growth in natural gas infrastructure. Fundamentals show solid revenue growth, with 2025 revenue at $16.94 billion and net income margin improving to 19.31%.
The outlook is positive due to contracted cash flows and a robust project pipeline, but risks include high debt levels and exposure to energy market volatility. Analyst sentiment is mixed, with a near-even split between buy and hold ratings. The stock offers a dividend yield supported by stable cash generation, though valuation multiples like a P/E of 20.31 may limit near-term upside.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Charles River Laboratories Intl. Inc
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →About Kinder Morgan Inc
Kinder Morgan is one of the largest midstream energy firms in North America, with an interest in or an operator on about 83,000 miles in pipelines and over 140 storage terminals. The company is active in the transportation, storage, and processing of natural gas, crude oil, refined products, natural gas liquids, and carbon dioxide. The majority of Kinder Morgan's cash flows stem from fee-based contracts for handling, moving, and storing fossil fuel products.
Read more on KMI →
